5-Bromo-2-nitropyridine → tert-butyl (3S)-3-methyl-4-(6-nitropyridin-3-yl)piperazine-1-carboxylate

HRID 1411579Notes

Reaction equation

HRID 1411579 reaction equation
[N+:1]([C:4]1[N:9]=[CH:8][C:7]([N:10]2[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:12][CH2:11]2)=[CH:6][CH:5]=1)([O-:3])=[O:2].Br[C:24]1C=CC([N+]([O-])=O)=NC=1.C(OC(N1CCN[C@@H](C)C1)=O)(C)(C)C>>[CH3:24][C@@H:15]1[N:10]([C:7]2[CH:8]=[N:9][C:4]([N+:1]([O-:3])=[O:2])=[CH:5][CH:6]=2)[CH2:11][CH2:12][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:14]1

Participants

4

Procedure

Following the procedures as described for compound 101g, reaction of 5-bromo-2-nitropyridine (10.5 g, 50 mmol), and (35)-tert-butyl-3-methylpiperazine-1-carboxylate (10.0 g, 50 mmol) afforded 130a as a yellow solid (8.05 g, 50%). LCMS: [M+H]+ 323

Sources & evidence

ORD record
ord-205d0838deb24a5889511faa6ac49966
Source dataset
uspto-grants-2014_12
Patent number
US08921353B2

Reaction notes

Loading…